- Report
- January 2024
- 200 Pages
Global
From €3867EUR$4,000USD£3,324GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- January 2023
- 197 Pages
Global
From €4756EUR$5,092USD£3,950GBP
- Report
- April 2023
- 90 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- April 2020
- 105 Pages
Europe
From €2030EUR$2,100USD£1,745GBP
€2900EUR$3,000USD£2,493GBP
- Report
- April 2020
- 100 Pages
Asia Pacific
From €2030EUR$2,100USD£1,745GBP
€2900EUR$3,000USD£2,493GBP
- Report
- March 2020
- 134 Pages
North America
From €2030EUR$2,100USD£1,745GBP
€2900EUR$3,000USD£2,493GBP
- Report
- January 2021
- 128 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- January 2021
- 68 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
- Report
- January 2021
- 64 Pages
North America
From €1450EUR$1,500USD£1,246GBP
- Report
- January 2021
- 68 Pages
Asia Pacific
From €1450EUR$1,500USD£1,246GBP
- Report
- February 2024
- 174 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Book
- April 2024
- 400 Pages
The biosecurity market is a subset of the biodefense industry, which focuses on the development of products and services to protect against biological threats. These threats can include naturally occurring diseases, bioterrorism, and emerging infectious diseases. Biosecurity products and services are designed to detect, prevent, and respond to biological threats. These products and services include diagnostics, vaccines, therapeutics, medical countermeasures, and decontamination systems.
Biosecurity is a rapidly growing market, driven by increasing awareness of the potential for biological threats and the need for effective countermeasures. Governments, militaries, and private companies are investing in biosecurity products and services to protect their citizens, personnel, and assets.
Some companies in the biosecurity market include BioFire Defense, Emergent BioSolutions, DynPort Vaccine Company, and PharmAthene. Show Less Read more